Cryptococcus neoformans (Sanfelice) Vuillemin (ATCC® 90113)

Alternate State: Filobasidiella neoformans Kwon-Chung  /  Strain Designations: 7241/9.829 MCV 13 [NCCLS 98]  /  Product Format: freeze-dried

Deposited As Cryptococcus neoformans (Sanfelice) Vuillemin, anamorph
Strain Designations 7241/9.829 MCV 13 [NCCLS 98]
Alternate State Filobasidiella neoformans Kwon-Chung
susceptibility testing antifungal agents
Biomedical Research and Development Material
Biosafety Level 2
Product Format freeze-dried
Type Strain no
Preceptrol® no
Autonomous effect of combination of fluconazole and flucytosine
Medium ATCC® Medium 200: YM agar or YM broth
Growth Conditions
Temperature: 24.0°C
Sequenced Data
No DNA sequencing was performed in house on this product.
Name of Depositor A Espinel-Ingroff
cerebrospinal fluid, Pennsylvania

Espinel-Ingroff A, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30: 3138-3145, 1992. PubMed: 1452697

Nguyen MH, et al. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob. Agents Chemother. 39: 1691-1695, 1995. PubMed: 7486902